Role of natural and synthetic compounds in modulating NRF2/KEAP1 signaling pathway in prostate cancer

G Tossetta, S Fantone, D Marzioni, R Mazzucchelli - Cancers, 2023 - mdpi.com
Simple Summary Several studies showed that oxidative stress is involved in cancer
occurrence, development, progression chemoresistance and radio resistance. The nuclear …

[HTML][HTML] The androgen receptor in prostate cancer: Effect of structure, ligands and spliced variants on therapy

EA Messner, TM Steele, MM Tsamouri, N Hejazi… - Biomedicines, 2020 - mdpi.com
The androgen receptor (AR) plays a predominant role in prostate cancer (PCa) pathology. It
consists of an N-terminal domain (NTD), a DNA-binding domain (DBD), a hinge region (HR) …

Prostate cancer incidence under androgen deprivation: nationwide cohort study in trans women receiving hormone treatment

I de Nie, CJM de Blok, TM van der Sluis… - The Journal of …, 2020 - academic.oup.com
Context Trans women (male sex assigned at birth, female gender identity) mostly use
antiandrogens combined with estrogens and can subsequently undergo vaginoplasty …

Cholesterol accumulation in prostate cancer: a classic observation from a modern perspective

JR Krycer, AJ Brown - Biochimica et Biophysica Acta (BBA)-Reviews on …, 2013 - Elsevier
Prostate cancer (PCa) is the most common cancer in men in developed countries.
Epidemiological studies have associated high blood-cholesterol levels with an increased …

Targeting continued androgen receptor signaling in prostate cancer

C Massard, K Fizazi - Clinical Cancer Research, 2011 - aacrjournals.org
Prostate cancer is the most common cancer and the second leading cause of death from
cancer in males in most Western countries. Prostate cancer has an exquisite sensitivity to …

Mouse models of prostate cancer: picking the best model for the question

MM Grabowska, DJ DeGraff, X Yu, RJ **… - Cancer and Metastasis …, 2014 - Springer
Abstract When the National Institutes of Health Mouse Models of Human Cancer Consortium
initiated the Prostate Steering Committee 15 years ago, there were no genetically …

Androgen receptor as a driver of therapeutic resistance in advanced prostate cancer

B Kahn, J Collazo, N Kyprianou - International journal of …, 2014 - pmc.ncbi.nlm.nih.gov
The role of the androgen receptor (AR) signaling axis in the progression of prostate cancer
is a cornerstone to our understanding of the molecular mechanisms causing castration …

Effects of 1α, 25 dihydroxyvitamin D3 and testosterone on miRNA and mRNA expression in LNCaP cells

WLW Wang, N Chatterjee, SV Chittur, JE Welsh… - Molecular cancer, 2011 - Springer
Background There is evidence from epidemiological and in vitro studies that the biological
effects of testosterone (T) on cell cycle and survival are modulated by 1, 25-dihydroxyvitamin …

In silico ADMET analysis of the A-, B-and D-modified androstane derivatives with potential anticancer effects

TL Šestić, JJ Ajduković, MA Marinović, ET Petri… - Steroids, 2023 - Elsevier
The major challenge in the fight against cancer is to design new drugs that will be more
selective for cancer cells, with fewer side effects. Synthetic steroids such as cyproterone …

[HTML][HTML] Prostate cancer stem cells: research advances

D Jaworska, W Król, E Szliszka - International journal of molecular …, 2015 - mdpi.com
Cancer stem cells have been defined as cells within a tumor that possesses the capacity to
self-renew and to cause the heterogeneous lineages of cancer cells that comprise the tumor …